Cleared Traditional

K912564 - MEGA PERICARDIOCENTESIS KIT

K912564 is the FDA 510(k) clearance for MEGA PERICARDIOCENTESIS KIT by Mega Medical, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K912564 · Mega Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1991
Decision
86d
Days
Class 2
Risk

K912564 is an FDA 510(k) clearance for the MEGA PERICARDIOCENTESIS KIT. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Mega Medical, Inc. (Tampa, US). The FDA issued a Cleared decision on September 5, 1991 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Mega Medical, Inc. devices

Submission Details

510(k) Number K912564 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 1991
Decision Date September 05, 1991
Days to Decision 86 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 125d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 483
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K912564.
SCIMED 8 FR. TRIGUIDEFLEX GUIDING CATHETERS
K913830 · Scimed Life Systems, Inc. · Nov 1991
CORDIS PTCA GUIDING CATHETER, MODIFICATION
K913783 · Dow Corning Wright · Oct 1991
CORDIS 7 FRENCH 0.072 I.D. PTCA GUIDING CATHETER
K912777 · Cordis Corp. · Sep 1991
TURBO SUPPORT CATHETER
K910116 · Datascope Corp. · Jun 1991
CATHCAP, CAT. NO. CC100 SERIES
K911519 · Gish Biomedical, Inc. · May 1991
NEW USCI 7F PTCA GUIDING CATHETER
K905249 · C.R. Bard, Inc. · Feb 1991